XNASGDRX
Market cap1.73bUSD
Jan 10, Last price
4.55USD
1D
6.31%
1Q
-34.06%
IPO
-90.26%
Name
GoodRx Holdings Inc
Chart & Performance
P/E
—
P/S
2.31
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
2.50%
Rev. gr., 5y
24.63%
Revenues
750m
-2.12%
Net income
-9m
L-72.99%
CFO
138m
-5.78%
Earnings
Feb 26, 2025
Profile
GoodRx Holdings, Inc., through its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices through GoodRx codes that are used to save money on prescriptions across the United States. It also offers other healthcare products and services, including subscriptions, pharma manufacturer solutions, and telehealth services. It serves pharmacy benefit managers that manage formularies and prescription transactions, including establishing pricing between consumers and pharmacies. The company was incorporated in 2015 and is headquartered in Santa Monica, California.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|
| 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||
Revenues | 750,265 -2.12% | 766,554 2.83% | ||||||
Cost of revenue | 669,604 | 710,639 | ||||||
Unusual Expense (Income) | ||||||||
NOPBT | 80,661 | 55,915 | ||||||
NOPBT Margin | 10.75% | 7.29% | ||||||
Operating Taxes | (46,704) | 9,597 | ||||||
Tax Rate | 17.16% | |||||||
NOPAT | 127,365 | 46,318 | ||||||
Net income | (8,868) -72.99% | (32,828) 29.99% | ||||||
Dividends | ||||||||
Dividend yield | ||||||||
Proceeds from repurchase of equity | (103,974) | (113,197) | ||||||
BB yield | 3.78% | 5.88% | ||||||
| Debt | ||||||||
Debt current | 21,141 | 11,097 | ||||||
Long-term debt | 750,686 | 764,126 | ||||||
Deferred revenue | (23,498) | |||||||
Other long-term liabilities | 8,177 | 7,557 | ||||||
Net debt | 84,531 | (942) | ||||||
| Cash flow | ||||||||
Cash from operating activities | 138,292 | 146,780 | ||||||
CAPEX | (1,043) | (55,214) | ||||||
Cash from investing activities | (55,766) | (210,498) | ||||||
Cash from financing activities | (167,395) | (120,226) | ||||||
FCF | 135,452 | 22,096 | ||||||
| Balance | ||||||||
Cash | 672,296 | 757,165 | ||||||
Long term investments | 15,000 | 19,000 | ||||||
Excess cash | 649,783 | 737,837 | ||||||
Stockholders' equity | (1,457,363) | (1,448,495) | ||||||
Invested Capital | 2,944,745 | 2,964,405 | ||||||
ROIC | 4.31% | 1.57% | ||||||
ROCE | 5.42% | 3.63% | ||||||
| EV | ||||||||
Common stock shares outstanding | 410,315 | 412,858 | ||||||
Price | 6.70 43.78% | 4.66 -85.74% | ||||||
Market cap | 2,749,110 42.89% | 1,923,918 -85.30% | ||||||
EV | 2,833,642 | 1,922,976 | ||||||
EBITDA | 192,433 | 110,092 | ||||||
EV/EBITDA | 14.73 | 17.47 | ||||||
Interest | 56,728 | 34,243 | ||||||
Interest/NOPBT | 70.33% | 61.24% | ||||||